The emerging role of ACE2 in physiology and disease

被引:331
作者
Hamming, I.
Cooper, M. E.
Haagmans, B. L.
Hooper, N. M.
Korstanje, R.
Osterhaus, A. D. M. E.
Timens, W.
Turner, A. J.
Navis, G.
van Goor, H.
机构
[1] Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Groningen, Netherlands
[3] Baker Med Res Inst, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Austin & Repatriatr Med Ctr, Heidelberg West, Vic, Australia
[5] Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands
[6] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Proteolysis Res Grp, Leeds, W Yorkshire, England
[7] Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
关键词
ACE2; RAAS; ACE; renin; angiotensin;
D O I
10.1002/path.2162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The renin-angiotensin-aldosterone system (RAAS) is a key regulator of systemic blood pressure and renal function and a key player in renal and cardiovascular disease. However, its (patho)physiological roles and its architecture are more complex than initially anticipated. Novel RAAS components that may add to our understanding have been discovered in recent years. In particular, the human homologue of ACE (ACE2) has added a higher level of complexity to the RAAS. In a short period of time, ACE2 has been cloned, purified, knocked-out, knocked-in; inhibitors have been developed; its 3D structure determined; and new functions have been identified. ACE2 is now implicated in cardiovascular and renal (patho)physiology, diabetes, pregnancy, lung disease and, remarkably, ACE2 serves as a receptor for SARS and NL63 coronaviruses. This review covers available information on the genetic, structural and functional properties of ACE2. Its role in a variety of (patho)physiological conditions and therapeutic options of modulation are discussed. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 102 条
[81]   Developmental expression of ACE2 in the SHR kidney: A role in hypertension? [J].
Tikellis, C. ;
Cooper, M. E. ;
Bialkowski, K. ;
Johnston, C. I. ;
Burns, W. C. ;
Lew, R. A. ;
Smith, A. I. ;
Thomas, M. C. .
KIDNEY INTERNATIONAL, 2006, 70 (01) :34-41
[82]   Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy [J].
Tikellis, C ;
Johnston, CI ;
Forbes, JM ;
Burns, WC ;
Burrell, LM ;
Risvanis, J ;
Cooper, ME .
HYPERTENSION, 2003, 41 (03) :392-397
[83]   A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase [J].
Tipnis, SR ;
Hooper, NM ;
Hyde, R ;
Karran, E ;
Christie, G ;
Turner, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33238-33243
[84]   The angiotensin-converting enzyme gene family: genomics and pharmacology [J].
Turner, AJ ;
Hooper, NM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (04) :177-183
[85]   Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies [J].
Valdés, G ;
Neves, LAA ;
Anton, L ;
Corthorn, J ;
Chacón, C ;
Germain, AM ;
Merrill, DC ;
Ferrario, CM ;
Sarao, R ;
Penninger, J ;
Brosnihan, KB .
PLACENTA, 2006, 27 (2-3) :200-207
[86]   Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase [J].
Vickers, C ;
Hales, P ;
Kaushik, V ;
Dick, L ;
Gavin, J ;
Tang, J ;
Godbout, K ;
Parsons, T ;
Baronas, E ;
Hsieh, F ;
Acton, S ;
Patane, M ;
Nichols, A ;
Tummino, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :14838-14843
[87]   Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells [J].
Warner, FJ ;
Lew, RA ;
Smith, IA ;
Lambert, DW ;
Hooper, NM ;
Turner, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) :39353-39362
[88]   Angiotensin-converting enzyme-2: a molecular and cellular perspective [J].
Warner, FJ ;
Smith, AI ;
Hooper, NM ;
Turner, AJ .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) :2704-2713
[89]   Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus [J].
Weiss, SR ;
Navas-Martin, S .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2005, 69 (04) :635-+
[90]   Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications [J].
Wolf, G ;
Ritz, E .
KIDNEY INTERNATIONAL, 2005, 67 (03) :799-812